Company Filing History:
2 out of 3 
2 out of 9 
1 out of 1 Years Active: 2003-2009
Title: Yigong Ge: Innovator in Nucleic Acid Binding Compounds
Introduction
Yigong Ge is a prominent inventor based in South San Francisco, CA (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds that interact with nucleic acids. With a total of 5 patents to his name, Ge's work has the potential to impact both medicine and agriculture.
Latest Patents
Among his latest patents, Ge has developed halogen-substituted thienyl compounds. These compounds exhibit potential as nucleic acid binders, especially for double-stranded DNA, and as antibiotic agents. Another notable patent involves charged compounds that comprise a nucleic acid binding moiety. These compounds have localized positive charges and are designed for various applications, including methods to prevent or inhibit infections in both human and animal medicine.
Career Highlights
Yigong Ge has worked with several companies throughout his career, including Genesoft, Inc. and Genesoft Pharmaceuticals, Inc. His innovative research has positioned him as a key figure in the development of new therapeutic compounds.
Collaborations
Ge has collaborated with notable professionals in his field, including Matthew J. Taylor and Eldon E. Baird. These partnerships have further enhanced his research and development efforts.
Conclusion
Yigong Ge's contributions to the field of nucleic acid binding compounds demonstrate his innovative spirit and commitment to advancing science. His work continues to pave the way for new medical and agricultural applications.